Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2025
Early Prognostic Factors for Reduced Survival in Autoimmune Hepatitis: A Systematic Review With Meta-Analysis.
СтатьяСистематический обзорМетаанализНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Slooter Charlotte D, Troyer Isabelle D M, van den Brand Floris F, de Vries Ralph, Heymans Martijn W, Heneghan Micheal A, Drenth Joost P H, de Boer Ynto S
Аннотация
BACKGROUND & AIMS: Autoimmune hepatitis (AIH) is a severe, life-threatening condition for some patients. This systematic review aimed to identify and rank early prognostic factors associated with reduced survival in AIH.
METHODS: A systematic search was conducted in Ovid Medline and embase.com up to April 2024 for identifying early prognostic factors for the combined endpoints of death or liver transplantation and liver-related death or liver transplantation. Overview tables of prognostic factors were constructed to outline the number of studies, the respective effect direction, and the statistical significance. Meta-analysis was performed if at least 3 studies reported on a factor. The level of certainty in evidence was evaluated using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) guideline.
RESULTS: Thirty-three studies were included, and 44 prognostic factors were investigated in at least 2 studies. Cirrhosis at diagnosis (hazard ratio [HR], 3.21; 95% confidence interval [CI], 2.38-4.34) and insufficient response to therapy (HR, 4.35; 95% CI, 2.5-7.58) were significant predictors with the highest risk ratios. Additional factors associated with reduced survival include advanced age, non-Caucasian ethnicity, variant syndrome with primary sclerosing cholangitis, asymptomatic presentation, higher relapse rates and elevated international normalized ratio, creatinine, alkaline phosphatase/aspartate aminotransferase ratio, and Model for End-stage Liver Disease score. Protective factors include elevated baseline levels of aminotransferases and albumin levels.
CONCLUSIONS: Cirrhosis and insufficient treatment response are the prognostic factors with the highest impact on reduced survival in AIH. Other risk factors include advanced age, non-Caucasian ethnicity, primary sclerosing cholangitis-variant syndrome, asymptomatic presentation, higher relapse rates and elevated international normalized ratio, creatinine, alkaline phosphatase/aspartate aminotransferase ratio, and Model for End-stage Liver Disease score, whereas elevated baseline aminotransferases and albumin are protective.
METHODS: A systematic search was conducted in Ovid Medline and embase.com up to April 2024 for identifying early prognostic factors for the combined endpoints of death or liver transplantation and liver-related death or liver transplantation. Overview tables of prognostic factors were constructed to outline the number of studies, the respective effect direction, and the statistical significance. Meta-analysis was performed if at least 3 studies reported on a factor. The level of certainty in evidence was evaluated using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) guideline.
RESULTS: Thirty-three studies were included, and 44 prognostic factors were investigated in at least 2 studies. Cirrhosis at diagnosis (hazard ratio [HR], 3.21; 95% confidence interval [CI], 2.38-4.34) and insufficient response to therapy (HR, 4.35; 95% CI, 2.5-7.58) were significant predictors with the highest risk ratios. Additional factors associated with reduced survival include advanced age, non-Caucasian ethnicity, variant syndrome with primary sclerosing cholangitis, asymptomatic presentation, higher relapse rates and elevated international normalized ratio, creatinine, alkaline phosphatase/aspartate aminotransferase ratio, and Model for End-stage Liver Disease score. Protective factors include elevated baseline levels of aminotransferases and albumin levels.
CONCLUSIONS: Cirrhosis and insufficient treatment response are the prognostic factors with the highest impact on reduced survival in AIH. Other risk factors include advanced age, non-Caucasian ethnicity, primary sclerosing cholangitis-variant syndrome, asymptomatic presentation, higher relapse rates and elevated international normalized ratio, creatinine, alkaline phosphatase/aspartate aminotransferase ratio, and Model for End-stage Liver Disease score, whereas elevated baseline aminotransferases and albumin are protective.